What have we learned from the DanGer Shock trial?
06/03/24 • 12 min
With David Morrow, Brigham and Women's Hospital, Boston - United States of America & Christian Hassager, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark.
Results of a breakthrough study on circulatory support in patients with AMI-CS.
With David Morrow, Brigham and Women's Hospital, Boston - United States of America & Christian Hassager, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark.
Results of a breakthrough study on circulatory support in patients with AMI-CS.
Previous Episode
Stress cardiomyopathies in the acute setting- what to do and what not to do
With Guido Tavazzi, University of Pavia, Pavia - Italy & Thomas Lüscher, Royal Brompton Hospital Imperial College London, London - United Kingdom of Great Britain & Northern.
Aetiology and management of stress cardiomyopathies in acute settings.
Next Episode
No more beta-blockers after AMI? The results of the REDUCE-AMI trial
With Sean van Depen, University of Alberta, Edmonton - Canada, and Bertil Lindahl, Uppsala University, Uppsala - Sweden.
Highlights from the REDUCE-AMI trial.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/acvc-cardio-talk-495411/what-have-we-learned-from-the-danger-shock-trial-65623288"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to what have we learned from the danger shock trial? on goodpods" style="width: 225px" /> </a>
Copy